Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasm, Residual × Carmustine × 30 days × Clear all

Sponsor

Conditions

Lymphoma 2 Pediatric Brain Tumor 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large B-Cell, Diffuse 1 Immunoblastic Lymphadenopathy 1 Hodgkin Disease 1 Enteropathy-Associated T-Cell Lymphoma 1

Interventions

blinatumomab 2 Melphalan 2 Cyclophosphamide 2 trastuzumab deruxtecan 1 tislelizumab 1 tisagenlecleucel 1 thymoglobulin 1 pembrolizumab 1 palbociclib 1 nilotinib 1 fludarabine phosphate 1 fludarabine 1 avelumab 1 Whole-Body Irradiation 1 Trastuzumab 1 Sirolimus 1 Rituximab 1 Radiotherapy 1 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 1 Mycophenolic Acid 1 Monatide (IMS 3015) 1 Levetiracetam 1 Imatinib Mesylate 1 Hydroxychloroquine 1 Hematologic Tests 1 HMPL-013 1 Dasatinib 1 Cytarabine 1 Capecitabine 1 Busulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡